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Abstract 
 
Background: Our aim was to evaluate the clinical impact of routine amniotic fluid and 
neonatal surface swab microbiology at caesarean section. 
Materials and methods: Microbiology data from 1537 neonates delivered by 
caesarean section were analysed in the light of clinical outcome. 
Results: 1340 (87%) neonates had non-pathogenic bacteria or negative culture 
results from both amniotic fluid and surface swab samples. Of the 197 (13%) neonates 
with pathogenic bacteria, 22 (1.4%) were diagnosed with infection, but only in six (0.4%) 
were the bacteria presumed responsible for the infection. Amniotic fluid and surface swab 
culture had sensitivities of 54% and 35%, and positive predictive values of 14% and 17%, 
respectively, for detecting a neonate at risk of infection. 
Conclusion: Amniotic fluid and neonatal surface swab microbiology at caesarean 
section contributes little if anything to postnatal management and can be safely dropped 
from operative routine. 
 
 
 
Key words: amniotic fluid, surface swab, caesarean section, microbiology 
 
 
3 
 
 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
Introduction 
Early detection of neonates at increased risk of infection is of major clinical interest. 
Bacteriology of amniotic fluid samples and neonatal skin surface swabs at caesarean 
section was proposed as a predictor of infection during the first days of life 1, 2 and has 
been routinely performed in some institutions. However, there is ongoing debate as to 
whether isolates from these sources influence the development of neonatal infection and 
subsequent clinical management. Some authors have attributed adverse perinatal 
outcome to the bacteria isolated from amniotic fluid 3-9 and have proposed sampling 
amniotic fluid as an infection screening programme in preterms 3, 4. Others have 
contended that bacterial invasion of the amniotic cavity does not increase the risk of 
neonatal infection 10-13. There is even debate over the effects of Ureaplasma urealyticum 
on neonatal sepsis, meningitis and bronchopulmonary dysplasia 14-16. 
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Studies on this issue are rare. Most were conducted decades ago 1, 11 or limited to 
subgroups such as preterm neonates or mothers with premature rupture of the 
membranes 6, 7, 9. More particularly, sample sizes were small 6, 11-13. 
Our aim was to evaluate the utility of routine amniotic fluid and neonatal surface swab 
microbiology at caesarean section and its impact on subsequent clinical management, 
regardless of gestational age or other limiting factors. A key purpose was to determine the 
sensitivity and positive predictive value of the microbiology findings for neonatal infection.
4 
 
 
65 
66 
67 
68 
69 
70 
71 
72 
73 
74 
75 
Material and Methods 
Patient population. In a retrospective study over 24 months (July 2003 – June 2005) 
we analysed the microbiology data of all 1719 neonates delivered via caesarean section at 
the Department of Obstetrics, University Hospital Zurich, Switzerland. We excluded 182 
neonates on whom no amniotic fluid and skin surface microbiology had been performed. 
Gestational age in the remaining 1537 neonates ranged from 24 to 43 weeks (median 38 
weeks). Median birth weight was 2890g (range 260g to 5000g). 
Microbiological analysis and definitions. Amniotic fluid samples (n=1321) and 
neonatal cranial skin surface swabs (n=1486) were obtained at caesarean section. 
Amniotic fluid samples were transported (Portagerm®, bioMérieux, Marcy-l’Etoile, France) 
to the microbiology laboratory for immediate Gram staining, aerobic culture on Columbia 
sheep blood agar and chocolate agar, and anaerobic culture on Brucella agar (Becton, 
Dickinson & Company, Franklin Lakes, NJ, (BD)) enriched with thioglycolate broth (BD). 
A7 agar medium (bioMérieux) and Urée-Arginine Lyo 2© (bioMérieux), a ready-to-use 
urea- and arginine-containing broth-based system for detecting urogenital mycoplasmas, 
were used to detect 
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Mycoplasma hominis and U. urealyticum. Surface swab samples were 
cultured aerobically on sheep blood agar, McConkey agar, colistin-nalidixic acid agar, 
chocolate agar, and streptococcal selective agar. Isolates were identified using standard 
procedures. Microbiology data from the amniotic fluid samples, surface swabs and follow-
up samples (blood culture, cerebrospinal fluid and tracheal aspirate) were obtained from 
the Institute of Medical Microbiology, University of Zurich. 
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86  Culture results were divided into two broad groups with respect to the clinical context: 
pathogenic (e.g., Enterobacteriaceae, U. urealyticum and β-haemolytic Streptococcus 
group B, in any amount) and non-pathogenic (e.g., lactobacilli, coagulase-negative 
staphylococci and viridans streptococci, also in any amount). Classification of low-virulent 
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bacteria, i.e., mixed anaerobic bacteria, enterococci or peptostreptococci, depended on 
the amount present: low amounts or bacteria detected only on enrichment culture were 
classified as non-pathogenic; moderate or abundant amounts were classified as 
pathogenic. Negative cultures were pooled with the non-pathogenic results. 
Clinical characteristics and definitions. Neonates were allocated to the following 
three groups: 1. No infection (no evidence of infection in the first six days of life); 
2. Prophylactic antibiotics (administered over several days postpartum due to perinatal risk 
factors, e.g., mother positive for β-haemolytic Streptococcus group B, prolonged 
premature rupture of the membranes for >24 hours, and acute chorioamnionitis); 
3. Infection (documented or suspected infection in the first six days of life). Clinical 
evidence of infection included respiratory distress syndrome, fever, hypotension, 
prolonged capillary refill time, hypoglycaemia and acidosis. Sepsis was diagnosed on the 
basis of a positive blood or cerebrospinal fluid culture combined with clinical signs. Clinical 
information was obtained from Zurich University Hospital’s neonatal clinical database and 
individual patient records. 
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Statistical analysis. The sensitivity, specificity and positive and negative predictive 
value of a pathogenic culture result for detecting a neonate at risk of infection were 
separately calculated from cross-tabulations of the amniotic fluid and surface swab data. 
Pathogenic culture results were compared with non-pathogenic culture results. Neonates 
allocated to groups 2 & 3 (Prophylactic antibiotics & Infection) were considered together as 
at risk for infection and compared with those in group 1 (No infection). 
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Results 
Neonate characteristics. Most neonates (1340/1537) had non-pathogenic or 
negative culture results from both amniotic fluid and surface swab (Figure 1). 1319/1340 
neonates showed no signs of infection (group 1); six neonates received prophylactic 
antibiotics (group 2) and 15 developed an infection (group 3). Cultures of amniotic fluid, 
surface swab or both were pathogenic in 197/1537 neonates, 170 of whom belonged to 
group 1, five to group 2, and the remaining 22 to group 3 (Infection). 
Analysis of the 22 neonates with infection and pathogenic amniotic fluid and/or 
surface swab cultures. Microbiological workup was performed in 20/22 neonates, in 14 of 
whom additional cultures were negative or non-pathogenic. However, in the remaining six 
neonates, cultures were positive for pathogens: β-haemolytic Streptococcus group B 
(n=1), 
121 
Klebsiella oxytoca (n=1), Escherichia coli (n=2) and other bacteria (n=2); each 
isolate was identical to that cultured from the amniotic fluid or surface swab, thus 
presumptive of a causal relationship with the neonatal infection. 
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Microbiological analysis. In total, 1321 amniotic fluid samples and 1486 surface 
swabs were tested; 430 and 456, respectively, proved positive, in most cases for more 
than one microorganism. In amniotic fluid, the most frequent isolates were coagulase-
negative staphylococci (n=180), U. urealyticum (n=100) and Propionibacterium spp. 
(n=43). Pathogenic isolates comprised β-haemolytic 
128 
Streptococcus group B (n=20), M. 
hominis
129 
 (n=15), Klebsiella spp. (n=5) and E. coli (n=4). Surface swabs grew skin flora 
(n=83), enterococci (n=43), coagulase-negative staphylococci (n=38) and viridans 
streptococci (n=31); well-known pathogens were β-haemolytic 
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Streptococcus group B 
(n=34) and 
132 
E. coli (n=14). 133 
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Amniotic fluid profile. 1167/1321 amniotic fluid cultures were non-pathogenic. 
1149/1167 of these neonates belonged in group 1, six in group 2 and 12 in group 3. 
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Cultures of the remaining 154/1321 amniotic fluid samples grew pathogens; the neonates 
concerned were distributed as follows: group 1, n=133; group 2, n=4; and group 3, n=17. 
Pathogenic amniotic fluid culture  had a sensitivity of 54% (21/39), a specificity of 90% 
(1149/1282), a positive predictive value of 14% (21/154) and a negative predictive value of 
99% (1149/1167) for detecting the risk of neonatal infection. 
Surface swab profile. 1399/1486 surface swab cultures were non-pathogenic. 
1371/1399 neonates belonged in group 1, nine in group 2 and 19 in group 3. Cultures of 
the remaining 87/1486 swabs grew pathogens, with the neonates concerned distributed as 
follows: group 1, n=72; group 2, n=1; and group 3, n=14. Pathogenic skin swab culture 
had a sensitivity of 35% (15/43), a specificity of 95% (1371/1443), a positive predictive 
value of 17% (15/87) and a negative predictive value of 98% (1371/1399) for detecting the 
risk of neonatal infection. 
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Discussion 
We evaluated the clinical impact of routine amniotic fluid and neonatal surface swab 
microbiology at caesarean section regardless of specific clinical constellation. Pathogens 
were detected in 197 (13%) of neonates, of whom only 22 (1.4%) developed an infection. 
To test for a causal relationship between the amniotic fluid and/or surface swab pathogen 
and the infection, we analysed the postnatal microbiology data and discovered that only in 
six cases were the resulting isolates identical to those grown from the amniotic fluid or 
surface swab. Thus pathogens detected at caesarean section can be presumed to have 
accounted for postnatal infection in no more than 0.4% of the total 1537 cases studied. 
The detection of infection risk by culturing amniotic fluid and neonatal surface swabs 
had a sensitivity of only 54% and 35%, respectively. Sensitivities would have been even 
lower if we had not considered neonates receiving prophylactic antibiotics (group 2) at risk 
for infection. Moreover, the positive predictive values of 14% for amniotic fluid and 17% for 
surface swabs reveal a disconnect between pathogen detection and development of 
infection. This is consistent with reports of possible microbial invasion of the amniotic 
cavity without demonstrable clinical signs of neonatal infection 12. Conversely, non-
pathogenic cultures had high negative predictive values for infection: 99% for amniotic fluid 
and 98% for surface swabs. 
Not only does routine amniotic fluid and surface swab screening have a low risk 
detection rate, it also provides no clinical information relevant to neonatal management. All 
22 neonates identified with infection and amniotic fluid or surface swab pathogens had 
already been treated with antibiotics due to their clinical presentation and risk factors. In 
none of the 22 infected infants did the amniotic fluid or surface swab result influence 
monitoring, antibiotic initiation or antibiotic choice. 
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Our data show that routine bacteriology of amniotic fluid and the neonatal surface at 
caesarean section contributes little if anything to neonatal management. In our population, 
most of the neonates were delivered at term. However, for preterms or neonates with 
serious perinatal risk factors, amniotic fluid analysis might be useful to complement clinical 
examination and microbiological workup; its positive predictive value might improve in this 
setting. Skin swab analysis, on the other hand, has no value and should be discarded 4. 
 
Conclusion 
Routine amniotic fluid and neonatal surface swab bacteriology at caesarean section 
contributes little if anything to clinical management. In view of its financial implications, 
such screening should not be performed routinely.
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